Sorry, you need to enable JavaScript to visit this website.

So far – So good!

You appear to meet the basic requirements for this COVID-19 vaccine study. However, only the research study staff can fully determine if they qualify to enroll. Please enter your information below.

So far – So good!

You appear to meet the basic requirements for this COVID-19 vaccine study. However, only the research study staff can fully determine if you qualify to enroll. To connect you with the research site, we will need to follow up with a few more questions. Parents/Guardians: please enter your information below, and a study representative will contact you in the next 1-2 days.

Sorry, you are not eligible at this time...

Thank you so much for your interest in this COVID-19 vaccine study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

Sorry, you are not eligible at this time...

Thank you so much for your interest in this COVID-19 vaccine study and for answering our questions. Contact your healthcare provider if you have any medical questions. Also, please consider entering your information below to be contacted about future clinical research opportunities.

Make a Difference for You and Other Expectant Moms

A new Pfizer & BioNTech COVID-19 vaccine study is underway for pregnant women. Answer a few questions to see if you may be able to participate.

Header

Question 1 of 4

Are you 18 years of age or older?

Yes
No

Question 2 of 4

Are you currently pregnant?

Yes
No

Question 3 of 4

Have you participated in any clinical trial for COVID‑19?

Yes
No

Question 4 of 4

Do you have a history of COVID‑19 infection or a positive COVID‑19 test?

Yes
No
manual address entry
Please select a full valid address.

Choose a Location

Select a research site near you. Study locations will be added frequently. If you don’t see a site near you then select, "The sites listed here are not convenient for me." A study representative will call you when a research site becomes available in your area.

The sites listed here are not convenient for me.

About The Maternal Study

COVID-19 continues to spread around the world. One critical step in fighting this pandemic is learning about the safety and effectiveness of the vaccine for all expectant mothers and their babies. Expectant moms who make the important and personal decision to volunteer for this study will help us answer this question. By choosing to volunteer, you will represent expectant moms like you—in age, race, ethnicity, and from communities like yours. You can help make a difference for other expectant moms and babies.

This study involves comparing an investigational (study) vaccine against a placebo (injection with no active ingredient).  Participants who are given the placebo will have the opportunity to receive the study vaccine shortly after giving birth.  Your participation in the study will last about 7-10 months.

Who Can Participate
 

  • Healthy women over 18 years old who are pregnant and expecting one child
  • Participants should be about 24-34 weeks (6-8 months) pregnant when they receive the study injection
  • Participants should not have been previously diagnosed with COVID-19
Header Image

What to Expect

icon

A computer will randomly assign you to receive either the study vaccine or placebo. Neither you nor the study doctor will know if you are receiving the study vaccine or a placebo. One half of the study participants will receive the study vaccine, and the other half will receive the placebo.

icon

The first 2 visits are when you receive the study vaccine or placebo through an injection in your arm. These visits are about 3 weeks apart.

icon

After you receive your study injections, you will have 2 follow-up visits before your baby is born and 2 follow-up visits after your baby is born to monitor your health. Your baby will also have a follow-up visit when they are about 6 months old.

icon

One month after your baby is born, you will learn if you received the placebo or the active study vaccine (called unblinding) while you were pregnant. Participants who received the placebo will then have the opportunity to receive their first dose of the active study vaccine.

icon

Over the course of the study, you will need to track any side effects that you may have. To make this easier, you will be given an electronic diary (e-diary). If you prefer, you can also download a secure app on your smartphone.

icon

You will be reimbursed for expenses (such as parking, meals, travel) and time related to completing the e-diary.

Header Image
Pfizer Logo
BioNTech Logo